RFP | December 10, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for implementation of the Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44) Grant. The purpose of this grant is to provide product development activities for radiological/nuclear medical countermeasures leading to investigational new drug or investigational device exemption submission packages to the U.S. Food and Drug Administration. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for this program . . .